Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634279 · ClinicalTrials.gov registry record · NA
Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses
A NA study, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
NCT04634279 is a NA study that has completed, run by RAND. The registered enrollment target is 68 participants.
The verdict
NCT04634279, a NA study, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and then test an enhanced version of the parent study's collaborative care intervention for co-occurring disorders (CC-COD) to reduce the risk of suicide and overdose among individuals with opioid use disorder (OUD) in combination with PTSD/depression. The parent study is CLARO, Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (NCT04559893).
Interventions
- BEHAVIORAL Collaborative care Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2022-08-31 |
| Est. Completion | 2024-06-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04634279
The ClinicalTrials.gov registry entry for NCT04634279 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RAND, which has 78 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Collaborative care Plus is the first listed.
NCT04634279 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04634279 about?
NCT04634279 is a clinical study titled "Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses". The purpose of this study is to develop and then test an enhanced version of the parent study's collaborative care intervention for co-occurring disorders (CC-COD) to reduce the risk of suicide and overdose among individuals with opioid use disorder (OUD) in combination with PTSD/depression. The par...
What is the current status of trial NCT04634279?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2022-08-31. Estimated completion is 2024-06-12.
What interventions are being tested in trial NCT04634279?
The interventions under investigation include: Collaborative care Plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT04634279?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.